WKN: | 853815 |
ISIN: | US0718131099 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Baxter International-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 19. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2000 | 17,00 | 25,75 | 51,47% |
2 | 1991 | 4,67 | 6,69 | 43,25% |
3 | 1995 | 5,19 | 7,27 | 40,08% |
4 | 1997 | 8,27 | 11,54 | 39,54% |
5 | 2019 | 56,51 | 74,51 | 31,85% |
6 | 2012 | 20,86 | 27,19 | 30,35% |
7 | 2017 | 41,39 | 53,86 | 30,13% |
8 | 1999 | 13,07 | 17,00 | 30,07% |
9 | 1989 | 3,52 | 4,55 | 29,26% |
10 | 2001 | 25,75 | 32,65 | 26,80% |
11 | 2005 | 13,69 | 17,09 | 24,84% |
12 | 2014 | 27,49 | 33,31 | 21,17% |
13 | 2016 | 35,18 | 41,39 | 17,65% |
14 | 2021 | 65,21 | 76,50 | 17,31% |
15 | 1996 | 7,27 | 8,27 | 13,76% |
16 | 1998 | 11,54 | 13,07 | 13,26% |
17 | 2007 | 19,06 | 21,49 | 12,75% |
18 | 2006 | 17,09 | 19,06 | 11,53% |
19 | 2009 | 20,64 | 22,16 | 7,36% |
20 | 2004 | 12,93 | 13,69 | 5,88% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 32,65 | 14,67 | -55,07% |
2 | 2022 | 76,50 | 47,60 | -37,78% |
3 | 2023 | 47,60 | 34,85 | -26,79% |
4 | 2025 | 27,50 | 20,30 | -26,18% |
5 | 2024 | 34,85 | 27,50 | -21,09% |
6 | 1993 | 6,35 | 5,13 | -19,21% |
7 | 2020 | 74,51 | 65,21 | -12,48% |
8 | 2003 | 14,67 | 12,93 | -11,86% |
9 | 2010 | 22,16 | 20,64 | -6,86% |
10 | 1992 | 6,69 | 6,35 | -5,08% |
11 | 2008 | 21,49 | 20,64 | -3,96% |
12 | 2011 | 20,64 | 20,86 | 1,07% |
13 | 2013 | 27,19 | 27,49 | 1,10% |
14 | 1994 | 5,13 | 5,19 | 1,17% |
15 | 1990 | 4,55 | 4,67 | 2,64% |
16 | 2018 | 53,86 | 56,51 | 4,92% |
17 | 2015 | 33,31 | 35,18 | 5,61% |
18 | 2004 | 12,93 | 13,69 | 5,88% |
19 | 2009 | 20,64 | 22,16 | 7,36% |
20 | 2006 | 17,09 | 19,06 | 11,53% |